Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

HealthDay News — For older adults with untreated hearing loss, a hearing intervention reduces social isolation, according to a study published in JAMA Internal Medicine. Nicholas S. Reed ...

The end of Cartoon Network will not only be a huge loss for the animation industry, but it could also result in new anime fans being reduced. Although hard to admit, it has become clear throughout ...

Eli Lilly already posted preliminary data showing its obesity drug, Zepbound topped Novo Nordisk’s Wegovy on measures of weight loss in a head-to-head clinical trial. More detailed results ...

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food and Drug Administration has approved a COVID-19 vaccine from Moderna ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Faf du Plessis and Rajat Patidar's 105-run stand for the second wicket and Wanindu Hasaranga's five-for laid the platform for Royal Challengers Bangalore's 67-run victory against Sunrisers ...

ABSTRACT: Individuals are always interacting and communicating with their environment, but there are many factors that affect the quality of this interaction and communication. These factors may be ...